丽珠医药(01513.HK)11月5日耗资人民币600万元回购16.4万股A股
Ge Long Hui·2025-11-05 11:06

Group 1 - The company, Lijun Pharmaceutical (01513.HK), announced a share buyback plan on November 5, 2025, involving an expenditure of RMB 6 million to repurchase 164,000 A-shares [1] - The buyback price per share is set between RMB 36.41 and RMB 36.64 [1]